| For: | Bouziane M, Moufid O, Habbal R. Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs. World J Exp Med 2026; 16(1): 112270 [PMID: 41883450 DOI: 10.5493/wjem.v16.i1.112270] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315x/full/v16/i1/112270.htm |
| Number | Citing Articles |
| 1 |
Pablo García-Pavía, Francesco Cappelli, Margot K. Davis, Marianna Fontana, Julian D. Gillmore, Mazen Hanna, Ahmad Masri, Laura Obici, Scott D. Solomon, Brett W. Sperry, Nobuhiro Tahara, Márcia Waddington-Cruz, Kurt Boman, Sarah A. M. Cuddy, Philippe Debonnaire, Nowell M. Fine, Piotr Podolec, Ali Yilmaz, Tom Conrad, Qingqing Yang, Brian L. Claggett, Jersey Chen, Sotirios Tsimikas, Mathew S. Maurer. Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial. Nature Medicine 2026; doi: 10.1038/s41591-026-04670-6
|
| 2 |
Giuseppe Barberis Barcia, Inés Toranzo-Nieto, Verónica González-Calle, Javier Maillo Seco, Leyre Álvarez Rodríguez, Jose C. Cañadas Salazar, Mónica García Monsalvo, Jose A. Muñoz León, Cristina Agullo Roca, Rocío Eiros Bachiller. Unmasking AL Cardiac Amyloidosis During Familial Cardiomyopathy Screening. JACC: Case Reports 2026; 31(38) doi: 10.1016/j.jaccas.2026.108991
|